Start date: 01 January 2018
End date: 31 December 2022
The main objective of this study is to identify the eligibility criteria for treatment with lithium in bipolar I disorders (BDI) in terms of response, safety and tolerability. R-LiNK proposes a pragmatic study of individuals with BDI when lithium treatment is initiated, to identify early biomarkers to stratify individuals with BDI according to their response to lithium assessed prospectively (two years).
Scientific coordinator of the project: Franck Bellivier